INTRODUCTION
Gastrointestinal symptoms (GISs) in patients with endstage renal disease (ESRD) show changes depending on uremia, the treatment model, changes in diet, and drugs used (1) and are also seen in 77-79% of these patients (2) . GISs show differences depending on the stage of chronic kidney disease (CKD) and type of renal replacement therapy. In a study conducted in hemodialysis (HD) patients, nausea (74%) was the most frequently reported GIS; further, vomiting, constipation, and diarrhea were found at rates of 68%, 59%, and 25%, respectively (3).
For diagnosis of Functional bowel disorders (FBDs) ; first alarm symptoms were excluded to suggest any organic disorders and then FBDs were diagnosed by the Manning or Rome criteria. First, they were defined using the Manning criteria (4). The Manning criteria were then developed as the Rome criteria. The Rome I, Rome II, and Rome III (2006) diagnostic criteria for FBDs were published (5) .
In according to the symptoms which exist on its own, FBDs are divided into five subgroups: irritable bowel syndrome (IBS), functional bloating, functional con-stipation, functional diarrhea and unspecified (6) . The prevalence of IBS varies according to the definition criteria in normal populations and ranges between 3.7% and 25% according to the Rome II criteria (7) . In Turkey, this rate has been reported to be 21% in the normal population and 44% in HD patients (8) . Functional constipation occurs in up to 27% of the normal population (9) . To the best of our knowledge, no study has compared functional constipation in a normal population with that in HD patients in Turkey.
It is known that the GISs are more common in patients with diabetes mellitus (DM) than in a healthy population (10) . However, in a study, there was no significant difference between patients with uremia with and those without DM in terms of the prevalence of GISs. Therefore, this suggests that the presence of DM does not cause GISs in this patient group (11) . In a study by Shakil et al. (12) , there was a significant relationship between the presence of DM and the increased incidence of constipation in patients with uremia.
In HD patients, there are few studies to evaluate the prevalence of FBDs and their subtypes and associated factors. The aim of our study was to determine the prevalence of FBDs and their subtypes and FBD-related risk factors in HD patients.
MATERIALS AND METHODS
This cross-sectional study included 80 patients who were older than 18 years, without alarm symptoms, who were diagnosed with CKD by taking the history and conducting physical examinations and clinical and laboratory tests, and received HD for more than 3 months (patient group) among 120 patients in our Nephrology Clinic. These patients were compared with 80 healthy controls with similar age and gender (control group). The study was conducted between March 2015 and January 2016. All patients underwent polysulfone and bicarbonate dialysis for 4 h three times a week. The blood flow rate and dialysate flow rate were set at 250-300 mL/min and 500 mL/min, respectively. People who had cognitive or cognitive dysfunction (memory loss, dementia, difficulty in understanding the question), acute or active infection in the last 3 months, a major surgical intervention in the last 6 months, and another known active disease history and those who were unwilling to participate were excluded.
The causes of CKD, the mean duration of HD, habits, additional diseases, and tests [hemoglobin (Hgb), albumin, calcium, phosphorus (P), and parathyroid hormone] performed at recent visits of the patients were recorded. The Kt/V value, which is used as an indicator of dialysis adequacy, was calculated from the equation described by Daugirdas (13) . In the definition of Kt/V, K is the dialyzer clearance of urea at a given blood flow rate (ml/min), t is the dialysis time in minutes, and V is the volume of distribution of urea (l). The Kt/V value should be between 1.2 and 1.4 in patients without DM and above 1.4 in patients with DM for adequate dialysis treatment (14) . The present study was approved by the Ethics Committee of Training and Research Hospital, and signed consent forms were received from the patient and control groups.
Functional bowel disorders were diagnosed according to the Rome II diagnostic criteria by excluding organic pathologies. Drossmann edited Rome II criteria in the book named " Functional Gastrointestinal Disorders" (15) . The Rome II diagnostic criteria were validated and previously used in Turkish patients by Kasap et al. (16) (Table 1) . A questionnaire was used to determine the prevalence and distribution of the subtypes of FBDs in the patient and control groups (ANNEX-1).
(ANNEX-1): These were questions used for IBS, functional bloating, functional constipation, functional diarrhea, and unspecified FBDs. In the evaluation of the questionnaire, it was decided that (1) was never or rarely, (2) was sometimes, (3) was often, (4) was almost, and (5) was always. Then the following questions were asked: A1: Did you have pain or discomfort around your stomach or belly in the last 1 year? A2: Did you have pain or discomfort around your stomach or belly in the last 3 months? A3: Did your pain or discomfort during the last 3 months change according to your complaints in the last 1 year? A4: Was pain or discomfort around your stomach or belly constantly since the last 1 year? A5: How old were you when this pain or discomfort began? A6: Mark the location of your pain or discomfort around your stomach or belly in the illustration (You can select more than one area). A7: If you have pain in more than one area, the pain in which area annoys you most? A8: Did the pain or discomfort around your stomach or belly since the last 1 year affect your daily life? A9: How bad was your pain or discomfort around your stomach or belly in the last 1 year? A10: Was there reduction in or relief from pain or discomfort around your stomach or belly on defecation in the last 1 year? A11: Did you defecate more frequently in the last 1 year since your pain 1 . The presence of abdominal discomfort or pain that is relieved with defecation and/or associated with a change in frequency of stools and/or associated with a change in the form (appearance) of stools. Those who had bowel complaints but who were not diagnosed with any FBDs were considered to have unspecified FBDs.
Statistical Analysis
Statistical data were obtained using Statistical Package for the Social Sciences, version 20.0. Results were expressed as mean±standard deviation. Dependent variables were the presence of FBDs and their subgroups, and independent variables were age, gender, occupation, marital status, education level, the presence of comorbid disease, drug use, smoking, alcohol use, and tests performed at patients' recent visits. Chisquare and independent sample t-tests were used. Values were expressed as mean±standard deviation. P<0.05 with a 95% confidence interval was considered to be statistically significant.
RESULTS
This study included 80 patients who were followed by the Nephrology Clinic, and these were compared with 80 controls. Of the 80 patients, 46 (57.5%) were males and 34 (42.5%) were females. Of the 80 controls, 43 (53.8%) were males and 37 (46.3%) were females. The average age of the patients was 62.13±12.92 years, and the average age of the controls was 60.45±9.85 years. Twenty-six (32.5%) patients had DM, and 37 (46.2%) had hypertension and/or coronary artery disease. The mean duration of dialysis was 57.48±59.23 (3-312) months, and the mean Kt/V value was 1.53±0.31. While 51 (63.7%) patients lived in rural areas and 29 (36.3%) lived in urban areas, the corresponding rates were 50 (62.5%) and 30 (37.5%) in the controls. While 13 (16.2%) patients and 30 (37.5%) controls were uneducated, 12 (15%) patients and 10 (12.5%) controls knew only to read/write. While 43 (53.8%) and 8 (10%) patients completed primary school and high school, respectively, 26 (32.5%) and 14 (17.5%) controls completed primary school and high school, respectively. Only the patient group had people with a university degree, and there were a total of 4 (5%). Among the patients, 30 (37.5%) were housewives, 3 (3.8%) were workers, 26 (32.5%) were farmers, 11 (13.7%) were officers, and 10 (12.5%) were in other professions; among the controls, 36 (45%) were housewives, 13 (16.2%) were workers, 19 (23.8%) were farmers, and 12 (15%) were officers. While 58 (72.5%) were married, 2 (2.5%) were single and 20 (25%) were widowed among the patients, 69 (86.2%) were married, 2 (2.5%) were single, and 9 (11.3%) were widowed among the controls. The clinical and biochemical characteristics and demographic data are summarized in Tables 2 and 3. The Rome II criteria were used to determine the prevalence of FBDs in the patient and control groups. FBDs were found in 22 (27.5%) patients and 10 (12.5%) controls, and this difference was statistically significant (p=0.01) ( Table 4) .
Functional bowel disorders were found in 32 individuals. In total, 68.7% and 31.3% of those with FBDs were respectively formed by the patients and healthy controls.
According to symptoms that exist on their own, FBDs are divided into four subgroups: IBS, functional bloating, functional constipation, and functional diarrhea. Among the patients, 7.5% had IBS, 3.8% had functional bloating, 16.3% had functional constipation. Among the controls, 2.5% had IBS, 8.8% had functional bloating, and 1.3% had functional constipation. Functional constipation was significantly higher in the patient group than in the control group (p=0.001). Functional diarrhea was not observed in either group (Table 5) .
Functional bowel disorders were significantly higher in women (p=0.004). The mean Kt/V value was 1.61±0.30, and the mean duration of dialysis was 58.73±56.73 months in the patients with FBD; there was no statistically significant difference between the two groups (p=0.9). There was no a statistically significant relationship between the groups with and those without FBDs in terms of the presence of additional diseases and smoking and alcohol use (p>0.05). The serum P level was significantly higher in the group with FBDs (p=0.03). Among the patients with FBDs, 16 (72.7%) lived in urban areas and 6 (27.3%) lived in rural areas. Although FBDs occurred at a higher rate in those living in urban areas, this difference was not statistically significant (p=0.3). Among the patients with FBDs, while 7 (31.8%) did not complete primary school, 15 (68.2%) graduated from primary school or above. The distribution was similar in the patients without FBDs. In terms of occupational distribution, it was observed that in the group with FBDs, the rate of housewives was statistically significantly higher (p=0.003) but that the rate of farmers was statistically significantly less (p=0.001). Among the patients with FBDs, 14 (63.6%) were married and 8 (36.4%) were single or widowed. Although the rate of those married was higher, this difference was not statistically significant (p=0.27) ( Tables 6 and 7) .
When the mean duration of dialysis was divided into subgroups such as ≤12,12-60, and ≥60 months and the mean Kt/V Patient group (n=80) Control group (n=80) Mean±SD (n %) Mean±SD (n %) Table 3 . Demographic data of the patient and control groups value was divided into subgroups such as ≤1.4 and >1.4, there was no statistically significant relationship between the subgroups and FBDs (p>0.05) ( Table 8) .
DISCUSSION
Chronic GISs are frequently seen in patients with CKD (17) and are observed at rates as high as 70% (11) . Although FBDs have no mortality risks, they are an important for public health because of the prevalence, negative impact on the quality of life, high cost, and failure of curative treatment (18) . There is no biomarker for diagnosing FBDs, and they are diagnosed according to symptomatic criteria. The Rome criteria are most commonly used in diagnosing FBDs (15) . In the present study, the Rome II questionnaire (11) was used as it was easy to understand and could be easily answered by the study participants.
The study included 80 patients with ESRD who received HD and 80 controls who met the inclusion criteria. FBDs were found in 22 (27.5%) patients; thus, FBDs were statistically significantly increased in the patient group than in the control group (p=0.01). Functional constipation is a common problem in HD patients (19) , and its prevalence is known to be 53% (20) . In a study in HD patients, chronic constipation was found in 40% of patients and chronic diarrhea was found in 24% of patients (2). In our study, functional bloating was found in 3.8% of the patients and 8.8% of the controls (p=0.19) and functional constipation was found in 16.3% of the patients and 1.3% of the controls (p=0.001). Functional constipation was statistically significantly increased in the patient group than in the control group. Functional diarrhea was not observed in both groups. Although the relationship between FBDs and gender was not fully clarified, it has been reported to be higher in women. The reason for this may be that female steroids reduce the pain threshold by affecting visceral sensitivity or the serotonin synthesis differences in the central nervous system between genders (21) . In a study performed in 196 HD patients by Fiderkiewicz et al. (17) IBS was found in 27 (13.8%) patients. This rate was 18% in women and 11% in men, but this difference was not statistically significant. In our study, there were 7 (31.8%) males and 15 (68.2%) females among the patients with FBDs who received HD, and FBDs were significantly higher in women (p=0.004).
In previous studies, it was found that upper GIS-related mortality was more common in the first 2 years of HD and decreased in the following years (22) . There are very few studies investigating the lower GISs. In our study, there was a statistically significant relationship between FBDs and the duration of HD.
In a study conducted in the general population by Kasap et al. (16) , it was reported that FBDs were statistically significantly less in single people than in married and widowed people and that it was approximately equal in both married and widowed people. In a study performed in Elazıg by Celebi et al. (23), there was no a statistically significant relationship between marital status and FBDs. In our study, among the patients with FBDs, 14 (63.6%) were married and 8 (36.4%) were single/widowed. Although married people were found at a higher rate, this difference was not statistically significant. In our study, among the patients with FBDs, while 7 (31.8%) did not complete primary school, 15 (68.2%) graduated from a primary school or above. The distribution was similar in patients without FBDs. Among the patients with FBDs, 16 (72.7%) lived in urban areas and 6 (27.3%) lived in rural areas. Although FBDs were found to be at a higher rate in people who lived in urban areas, this difference was not statistically significant (p=0.3).
In a study by Kasap et al. (16) , it has been reported that FBDs were higher in housewives and unemployed people and that IBS was higher in farmers, housewives, and unemployed people. In our study, among the patients with FBDs, 63.6% were housewives, 9.1% were workers, 9.1% were officers, and 4.5% were farmers. In terms of occupational distribution, it was observed that in the group with FBDs, the rate of housewives was statistically significantly higher (p=0.003) but that the rate of farmers was statistically significantly less (p=0.001).
Regardless of glycemic control, GISs are known to be more common in patients with DM than in the normal population (24) . In a study performed in patients with CKD, there was no statistically significant difference between those with and those without DM in terms of the prevalence of the symptoms of FBDs (11) . In a study conducted in HD patients, there was no statistically significant relationship between IBS and DM (17).
In our study, 31.8% of the patients had DM and 36.4% of them had coronary artery disease/hypertension. There was no statistically significant relationship between the presence of additional diseases and FBDs.
In a study by Kasap et al. (16) , there was no statistically significantly relationship between smoking and alcohol use and FBDs. In our study, while 31.8% used cigarettes and 4.5% drunk alcohol in the patient group, 36.2% used cigarettes and 6.9% drunk alcohol in the group without FBDs. However, there was no statistically significant difference between the two groups in terms of smoking and alcohol use.
In the literature, till date, there is no study showing the relationship between the development of FBDs and levels of serum P in HD patients. In our study, the serum P level was found to be 5.57±1.51 mg/dL in the group with FBDs and 4.94±1.05 in the group without FBDs; thus, the serum P level was significantly higher in the group with FBDs (p=0.03). The P level was ≤3. It is known that high Hgb levels in HD patients increase the quality of life. In a study, there was a statistically significant relationship between Hgb levels and the symptoms of IBS in HD patients (17) . In our study, there was no statistically significant difference between the group with and that without FBDs in terms of mean Hgb levels.
In a study by Fiderkiewicz et al. (17) , there was no statistically significantly relationship between the development of IBS and Kt/V in HD patients. While the mean duration of dialysis was 58.73±56.73 months and the mean Kt/V value was 1.61±0.30 in the group with FBDs, the mean duration of dialysis was 57.0±60.2 months and the mean Kt/V value was 1.50±0.31 in the group without FBDs. However, there was no statistically significant difference between the two groups. When the dialysis time of the patients was divided into subgroups such as ≤12 months, 12-60 months, and ≥60 months, the duration of dialysis was shown to have no effect on the development of FBDs.
In studies performed in HD patients, it has been reported that IBS was more common in the general population and was seen at rates between 11% and 44% (2). Although it is not fully understood, genetic factors, changes in bowel motility, visceral hypersensitivity, psychosocial factors, changes in the function of the central nervous system to stimulation, and changes in the serotonergic system play a role in its pathogenesis (25) .
The prevalence of IBS varies depending on the diagnostic criteria used, sex, age, and race. In a study conducted in the United Kingdom, it was reported that the prevalence of IBS was higher in dialysis patients than in those without renal insufficiency and randomly selected groups; this could be caused by uremia or uremia treatment (11) . In studies that investigated the prevalence of IBS in HD patients using the Rome II criteria, its prevalence was reported to be 11% in Australia (2), 11.5% in all European countries (26) , and 21% in England (11) . In a study conducted in Turkey, the prevalence of IBS was reported to be higher in chronic dialysis patients than in the normal population (8) . In our study, among the HD patients, 7.5% had IBS, 3.8% had functional bloating, and 16.3% had functional constipation. The prevalence of IBS was similar to that in the community, and there was no statistically significant difference between the patient and control groups.
Constipation is a common problem in patients with uremia due to causes such as the use of antacids containing aluminum, dehydration, and physical activity (27) . In our study, the prevalence of functional constipation was found to be higher in HD patients than in the controls. The reasons for this situation may be an intake of foods containing low fiber, vitamin C, and potassium (28) ; the use of excess ion-exchange resin (1); and prolonged total colonic transit time (19) .
Our study has several limitations. Firstly, this study was performed with a small number of patients in a single center. Further studies should be conducted with a greater number of patients in many centers. Secondly, additional symptoms that are not present in the Rome criteria should also be questioned due to the high comorbidity in HD patients (17) . Thirdly, the psychological status and the use of laxatives, which could affect GISs, were not evaluated. Fourthly, the relationship between the mean dialysis duration of the patients and the presence of FBDs was investigated, but the results were not compared by following the patients for a long time. Fifthly, the Rome III criteria that are known to give more meaningful and accurate results were not used in the present study, and this may have influenced the results.
Consequently, FBDs and the subgroup of functional constipation are more common in HD patients than in the healthy population. While the educational level and residential area do not have an effect on the development of FBDs, it is frequently observed in females and housewives.
While the mean duration of dialysis and the Kt/V value (one of the dialysis adequacy parameters) do not have an effect on the development of FBDs, high serum P levels have an effect, regardless of the serum calcium levels. The cause of this may be the use of phosphate binders or aluminum-containing drugs in this patient group. Thus, effective dialysis reducing the serum P levels may be useful in the suppression of the symptoms of FBDs.
Further studies are needed to investigate the role of hyperphosphatemia on the development of FBDs in HD patients worldwide due to the lack of studies conducted on this subject. Moreover, further long-term studies are needed to investigate the pathophysiology, etiology and risk factors of GISs in HD patients and the effect of these symptoms on the quality of life of patients.
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